Remove 2029 Remove Communication Remove Vaccines
article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.

article thumbnail

AI in Life Sciences: Exploring Innovation and Opportunities

Viseven

in 2029 , with a compound annual growth rate of 27.9%. Artificial intelligence can assist governments and healthcare institutions in combating pandemics , including monitoring and predicting outbreaks, speeding up diagnostics and research, repurposing existing drugs, and even accelerating vaccine design and development.

article thumbnail

Highlights from ESCMID Global 2024: AI, climate change and AMR

Hospital Pharmacy Europe

Communications in infectious diseases In times of global crisis, like the threat of AMR or the Covid-19 pandemic, scientists and healthcare professionals play a crucial role in communicating trusted and relevant information to the public.